AN EFFICIENT ISOLATION PLAN FOR EXTRACTION OF THE MUCILAGE COLLECTED FROM THE SEEDS WITHIN THE Lallemantia FOR PHARMACEUTICAL PURPOSE

This study aims to suggest an efficient mucilage isolation plan for three species of Lallemantia genus namely L. iberica, L. royleana, and L. peltata that are collected from various habitats of Iran and characterizes the resulted mucilage for medical use. Mucilage is a hydrocolloid polymer that is used in industry and pharmaceutical science. Species within Lallemantia genus contain mucilaginous seeds with therapeutic properties that were used by indigenous people in traditional Iranian medicine. Lallemantia mucilage has shown to be a suitable substrate for the administration of the drug. Consequently, usage of the Lallemantia seeds in the pharmaceutical industry can be desirable for the pharmaceutical and cosmetics industry.
For this reason, there will be a need for the proposal of an efficient, cheap, and simple method of mucilage extraction. This study shows that the performance of 1:60 designed liquid-solid ratio under neutral pH at 60° will lead to a high gain of mucilage with minor hydrolysis. Generally, the biochemical and biophysical assessment of the resulted mucilage showed the advantageous properties of Lallemantia seeds in pharmaceuticals science and oral vaccines.